Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database

Yan, Qingran; Bruni, Cosimo; Garaiman, Alexandru; Mihai, Carina; Jordan, Suzana; Becker, Mike Oliver; Elhai, Muriel; Dobrota, Rucsandra; Liubov, Petelytska; Henes, Joerg; Hachulla, Eric; Siegert, Elise; Balbir-Gurman, Alexandra; Cuomo, Giovanna; Riemekasten, Gabriela; Heitmann, Stefan; Beigi, Davide Mohammad Reza; Ullman, Susanne; Sfikakis, Petros; Ingegnoli, Francesca; Bernardino, Vera; Truchetet, Marie-Elise; Vonk, Madelon; Del Galdo, Francesco; Hoffmann-Vold, Anna-Maria; Shuang, Ye; Distler, Oliver

Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database

Autor(en):

Yan, Qingran; Bruni, Cosimo; Garaiman, Alexandru; Mihai, Carina; Jordan, Suzana; Becker, Mike Oliver; Elhai, Muriel; Dobrota, Rucsandra; Liubov, Petelytska; Henes, Joerg; Hachulla, Eric; Siegert, Elise; Balbir-Gurman, Alexandra; Cuomo, Giovanna; Riemekasten, Gabriela; Heitmann, Stefan; Beigi, Davide Mohammad Reza; Ullman, Susanne; Sfikakis, Petros; Ingegnoli, Francesca; Bernardino, Vera; Truchetet, Marie-Elise; Vonk, Madelon; Del Galdo, Francesco; Hoffmann-Vold, Anna-Maria; Shuang, Ye; Distler, Oliver

Tübinger Autor(en):

Henes, Jörg Christoph

Erschienen in:

Annals of The Rheumatic Diseases (2025), Bd. 84, H. 4, S. 620-631

Verlagsangabe:

Amsterdam : Elsevier

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.ard.2025.01.014

ISSN:

0003-4967